NL7209345A - - Google Patents

Info

Publication number
NL7209345A
NL7209345A NL7209345A NL7209345A NL7209345A NL 7209345 A NL7209345 A NL 7209345A NL 7209345 A NL7209345 A NL 7209345A NL 7209345 A NL7209345 A NL 7209345A NL 7209345 A NL7209345 A NL 7209345A
Authority
NL
Netherlands
Application number
NL7209345A
Other versions
NL169882B (nl
NL169882C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7209345A publication Critical patent/NL7209345A/xx
Publication of NL169882B publication Critical patent/NL169882B/xx
Application granted granted Critical
Publication of NL169882C publication Critical patent/NL169882C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE7209345,A 1971-07-05 1972-07-04 Werkwijze ter bereiding van een farmaceutisch preparaat, gevormd farmaceutisch preparaat en werkwijze ter bereiding van 21-steroidalcohol-(1-adamantaan carbonzuur)esters. NL169882C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3134971A GB1391443A (en) 1971-07-05 1971-07-05 Ester of betamethasone and its 9alpha-chloro analogue

Publications (3)

Publication Number Publication Date
NL7209345A true NL7209345A (cg-RX-API-DMAC10.html) 1973-01-09
NL169882B NL169882B (nl) 1982-04-01
NL169882C NL169882C (nl) 1982-09-01

Family

ID=10321802

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7209345,A NL169882C (nl) 1971-07-05 1972-07-04 Werkwijze ter bereiding van een farmaceutisch preparaat, gevormd farmaceutisch preparaat en werkwijze ter bereiding van 21-steroidalcohol-(1-adamantaan carbonzuur)esters.

Country Status (17)

Country Link
JP (1) JPS5644079B1 (cg-RX-API-DMAC10.html)
AR (2) AR194120A1 (cg-RX-API-DMAC10.html)
AU (1) AU464251B2 (cg-RX-API-DMAC10.html)
BE (1) BE785812A (cg-RX-API-DMAC10.html)
CA (1) CA983919A (cg-RX-API-DMAC10.html)
CH (1) CH609065A5 (cg-RX-API-DMAC10.html)
DE (1) DE2232827A1 (cg-RX-API-DMAC10.html)
DK (1) DK131474B (cg-RX-API-DMAC10.html)
FR (1) FR2144761B1 (cg-RX-API-DMAC10.html)
GB (1) GB1391443A (cg-RX-API-DMAC10.html)
IE (1) IE36529B1 (cg-RX-API-DMAC10.html)
IL (1) IL39821A (cg-RX-API-DMAC10.html)
NL (1) NL169882C (cg-RX-API-DMAC10.html)
NO (1) NO137754C (cg-RX-API-DMAC10.html)
PH (1) PH13195A (cg-RX-API-DMAC10.html)
SE (1) SE385904B (cg-RX-API-DMAC10.html)
ZA (1) ZA724598B (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49116217A (cg-RX-API-DMAC10.html) * 1973-01-03 1974-11-06
DE2512915A1 (de) * 1974-03-27 1975-10-09 Plurichemie Anstalt 16-methyl-9 alpha-halogen-steroide ester, aether und verfahren zu ihrer herstellung
JPS6163976U (cg-RX-API-DMAC10.html) * 1984-10-01 1986-05-01
NZ603107A (en) 2008-05-28 2014-03-28 Validus Biopharma Inc Non-hormonal steroid modulators of nf-kb for treatment of disease
WO2011127048A2 (en) 2010-04-05 2011-10-13 Validus Biopharma NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Also Published As

Publication number Publication date
AR194120A1 (es) 1973-06-22
DK131474C (cg-RX-API-DMAC10.html) 1975-12-08
JPS5644079B1 (cg-RX-API-DMAC10.html) 1981-10-16
NL169882B (nl) 1982-04-01
IE36529L (en) 1973-01-05
DE2232827A1 (de) 1973-01-18
AU464251B2 (en) 1975-08-21
NO137754C (no) 1978-04-19
SE385904B (sv) 1976-07-26
AR194553A1 (es) 1973-07-23
IL39821A0 (en) 1972-09-28
PH13195A (en) 1980-01-18
IL39821A (en) 1976-02-29
FR2144761B1 (cg-RX-API-DMAC10.html) 1976-03-05
BE785812A (fr) 1973-01-04
CH609065A5 (en) 1979-02-15
IE36529B1 (en) 1976-11-24
NL169882C (nl) 1982-09-01
GB1391443A (en) 1975-04-23
NO137754B (no) 1978-01-09
DK131474B (da) 1975-07-21
FR2144761A1 (cg-RX-API-DMAC10.html) 1973-02-16
ZA724598B (en) 1973-03-28
AU4420572A (en) 1974-01-10
CA983919A (en) 1976-02-17

Similar Documents

Publication Publication Date Title
DK131474C (cg-RX-API-DMAC10.html)
AR196074A1 (cg-RX-API-DMAC10.html)
AU2691671A (cg-RX-API-DMAC10.html)
AU2726271A (cg-RX-API-DMAC10.html)
AU2952271A (cg-RX-API-DMAC10.html)
AU3005371A (cg-RX-API-DMAC10.html)
AU2941471A (cg-RX-API-DMAC10.html)
AU2894671A (cg-RX-API-DMAC10.html)
AU2742671A (cg-RX-API-DMAC10.html)
AU2684071A (cg-RX-API-DMAC10.html)
AU2669471A (cg-RX-API-DMAC10.html)
AU2880771A (cg-RX-API-DMAC10.html)
AU2875571A (cg-RX-API-DMAC10.html)
AU2907471A (cg-RX-API-DMAC10.html)
AU2684171A (cg-RX-API-DMAC10.html)
AU2706571A (cg-RX-API-DMAC10.html)
AU2724971A (cg-RX-API-DMAC10.html)
AU2740271A (cg-RX-API-DMAC10.html)
AU2755871A (cg-RX-API-DMAC10.html)
AU3038671A (cg-RX-API-DMAC10.html)
AU3025871A (cg-RX-API-DMAC10.html)
AU2836771A (cg-RX-API-DMAC10.html)
AU2963771A (cg-RX-API-DMAC10.html)
AU2837671A (cg-RX-API-DMAC10.html)
AU2854371A (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee